[Indications for irradiated blood components: dose and side effects]
Standard
[Indications for irradiated blood components: dose and side effects]. / Eiermann, Thomas.
In: Beitr Infusionsther, Vol. 31, 1993, p. 70-73.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - [Indications for irradiated blood components: dose and side effects]
AU - Eiermann, Thomas
PY - 1993
Y1 - 1993
N2 - Transfusion-associated graft versus host disease (ta-GvHD) is a rare but almost lethal complication of blood transfusion in immunocompromised patients. To prevent ta-GvHD, irradiated blood products should be given to patients at risk: patients after bone marrow transplantation, newborns and children in the 1st year, patients with severe combined immunodeficiency, and patients receiving blood from first-degree relatives. Blood products should be irradiated at least with 30 Gy just before transfusion. With this regime in practice for 4 years, no complications and side effects were seen.
AB - Transfusion-associated graft versus host disease (ta-GvHD) is a rare but almost lethal complication of blood transfusion in immunocompromised patients. To prevent ta-GvHD, irradiated blood products should be given to patients at risk: patients after bone marrow transplantation, newborns and children in the 1st year, patients with severe combined immunodeficiency, and patients receiving blood from first-degree relatives. Blood products should be irradiated at least with 30 Gy just before transfusion. With this regime in practice for 4 years, no complications and side effects were seen.
M3 - SCORING: Zeitschriftenaufsatz
VL - 31
SP - 70
EP - 73
ER -
